DAEWOONG

1. Time

March 26 (Fri), 2021, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 18th financial statement and consolidated financial statement; Report on internal accounting management system operations status; Report on outside auditor designation

B. Motioned Bills: Agenda 1: Change of articles of association; Agenda 2: Designation of directors (three executive directors, two outside directors); Agenda 3: Designation of auditor (one fulltime auditor); Agenda 4: Case of appointing auditors; Agenda 5: Approval of director compensation limit; Agenda 6: Approval of auditor compensation limit

1. Time

March 30 (Fri), 2020, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 18th financial statement and consolidated financial statement; Report on internal accounting management system operations status

B. Motioned Bills: Agenda 2: Change of articles of association; Agenda 3: Case of appointing auditors; Agenda 4: Approval of director compensation limit; Agenda 5: Approval of auditor compensation limit

1. Time

March 22 (Fri), 2019, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 17th financial statement and consolidated financial statement; Report on internal accounting management system operations status

B. Motioned Bills: Agenda 1: Change of articles of association; Agenda 2: Approval of director compensation limit; Agenda 3: Approval of auditor compensation limit; Agenda 4: Approval of granting stock options

1. Time

March 23 (Fri), 2018, 09:00

2. Location

Daewoong Pharmaceutical HQ Bear Hall

3. Meeting Objectives

A. Report Items: Audit report and sales report; Report on the 16th financial statement and consolidated financial statement

B. Motioned Bills: Agenda 1: Case of appointing directors (2 in-company directors, 1 outside director); Agenda 2: Approval of director compensation limit; Agenda 3: Approval of auditor compensation limit; Agenda 4: Change of articles of association

Corperate Governance